PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,260 | -79.1% | 455,823 | -69.3% | 0.03% | -80.4% |
| Q1 2023 | $39,532 | +308.3% | 1,486,170 | +196.8% | 0.14% | +308.6% |
| Q4 2022 | $9,681 | -99.9% | 500,788 | +0.3% | 0.04% | -7.9% |
| Q3 2022 | $10,435,000 | +308.7% | 499,533 | +56.7% | 0.04% | +322.2% |
| Q2 2022 | $2,553,000 | +22.6% | 318,759 | +7.3% | 0.01% | +50.0% |
| Q1 2022 | $2,082,000 | -47.1% | 297,034 | +1.8% | 0.01% | -33.3% |
| Q4 2021 | $3,939,000 | -20.8% | 291,814 | -1.0% | 0.01% | -25.0% |
| Q3 2021 | $4,974,000 | -42.8% | 294,657 | -1.3% | 0.01% | -42.9% |
| Q2 2021 | $8,695,000 | -32.4% | 298,593 | -8.7% | 0.02% | -36.4% |
| Q1 2021 | $12,865,000 | +199.0% | 327,094 | +72.7% | 0.03% | +200.0% |
| Q4 2020 | $4,303,000 | -1.9% | 189,404 | -2.2% | 0.01% | -21.4% |
| Q3 2020 | $4,387,000 | – | 193,706 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |